Suppr超能文献

冠状动脉支架置入术后心房颤动的卒中预防。

Prevention of Stroke in Atrial Fibrillation After Coronary Stenting.

机构信息

From the Department of Internal Medicine (L.K., A.F., G.F., T.F.), University of Miami Miller School of Medicine, FL.

Cardiovascular Division, Washington University School of Medicine, St. Louis, MO (M.R.).

出版信息

Stroke. 2019 Aug;50(8):2125-2132. doi: 10.1161/STROKEAHA.119.026078. Epub 2019 Jul 15.

Abstract

Background and Purpose- The optimal antithrombotic strategy to balance thromboembolic and bleeding events, especially acute stroke, for patients with atrial fibrillation following coronary stenting remains a matter of debate. We conducted a network meta-analysis to identify the antithrombotic regimen associated with the lowest rate of bleeding and thromboembolic events in atrial fibrillation after coronary stenting. Methods- PubMed, Scopus, and Cochrane Central were searched for randomized controlled trials and observational studies of patients with atrial fibrillation after coronary stenting. The outcomes of interest were stroke, myocardial infarction, major adverse cardiac events, mortality, and major bleeding. A network meta-analysis was performed comparing the available antithrombotic regimens in the literature. Results- Three randomized and 15 observational studies were included, with a total of 23 478 participants. Median follow-up was 2 years. Network meta-analysis demonstrated that vitamin K antagonist plus single antiplatelet therapy or direct-acting oral anticoagulant plus single antiplatelet therapy were the most effective regimens in preventing stroke. Direct-acting oral anticoagulant regimens were associated with lower major bleeding rates than vitamin K antagonist regimens. Regimens with dual antiplatelet therapy were associated with lower rates of myocardial infarction. Vitamin K antagonist plus dual antiplatelet therapy was associated with a lower mortality and low-dose direct-acting oral anticoagulants with decreased major cardiovascular adverse events. Conclusions- Direct-acting oral anticoagulant regimens were associated with less major bleeding and major cardiovascular adverse events, but vitamin K antagonists were associated with decreased mortality and stroke. These results suggest that the decision of antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention needs to be individualized.

摘要

背景与目的-在冠状动脉支架置入术后合并心房颤动的患者中,平衡血栓栓塞和出血事件(尤其是急性脑卒中)的最佳抗栓策略仍存在争议。我们进行了一项网状meta 分析,以确定与冠状动脉支架置入术后合并心房颤动患者出血和血栓栓塞事件发生率最低相关的抗栓方案。

方法-检索 PubMed、Scopus 和 Cochrane Central 中的随机对照试验和观察性研究,纳入冠状动脉支架置入术后合并心房颤动的患者。主要观察终点为脑卒中、心肌梗死、主要不良心脏事件、死亡率和大出血。对文献中现有的抗栓方案进行网状 meta 分析。

结果-共纳入 3 项随机对照试验和 15 项观察性研究,共计 23478 例患者。中位随访时间为 2 年。网状 meta 分析结果显示,维生素 K 拮抗剂联合单种抗血小板治疗或直接作用的口服抗凝剂联合单种抗血小板治疗方案在预防脑卒中方面最为有效。直接作用的口服抗凝剂方案与较低的大出血发生率相关。双联抗血小板治疗方案与较低的心肌梗死发生率相关。维生素 K 拮抗剂联合双联抗血小板治疗方案与较低的死亡率相关,而低剂量直接作用的口服抗凝剂与降低主要心血管不良事件相关。

结论-直接作用的口服抗凝剂方案与较低的大出血和主要心血管不良事件相关,但维生素 K 拮抗剂与降低死亡率和脑卒中相关。这些结果表明,经皮冠状动脉介入治疗后合并心房颤动患者的抗栓治疗决策需要个体化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验